The areas that AI will penetrate will be, I think just in time everything. There's already robotic surgery that's done in many cases because robots can be more precise and then you lock the person down and the robot knows the road that it has to go on. The last piece though, I'm still looking for at least in terms of my investing, this AI for clinical trials. It's an area where there's such huge possibilities. If you speed up a blockbuster clinical trial by a month, that could be worth 100 million out of $100 million. And if you can prioritize all of them, which ones to try first? That could even be billions of dollars. We spent so much
The Sunday Times’ tech correspondent Danny Fortson brings on Vijay Pande, head of Andreessen Horowitz’s $1.5bn bio fund, to talk about how artificial intelligence is impacting healthcare (3:30), tools that “understand” biology (8:50), trying to eliminate cancer (12:50), trying to get techie founders to get into healthcare (14:25), America’s plunging life expectancy (18:00), the (potential) end of radiology (21:10), AI’s “hallucination" problem in healthcare (25:55), the future of therapy (29:00), putting healthcare on the Moore’s Law curve (33:10), using automation to slash the industry’s costs and inefficiencies (37:30), the next trillion dollar company (40:00), if capitalism is the best way to crack healthcare (45:40), and solving the billing problem(48:35).
Hosted on Acast. See acast.com/privacy for more information.